methylnitrosourea has been researched along with paclitaxel in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bliukhterova, NV; Fomina, MM; Korman, DB; Ostrovskaia, LA; Rykova, VA | 1 |
| Anderson, MW; Kelloff, GJ; Lantry, LE; Liu, Q; Lubet, RA; Wang, Y; Wiseman, RW; You, M; Zhang, Z | 1 |
| Kamiyama, Y; Okugawa, H; Sakaida, N; Tanaka, K; Tanano, A; Uemura, Y; Yamamoto, D | 1 |
| Gulati, A; Rai, A; Rajeshkumar, NV; Shord, S | 1 |
| Gulati, A; Rai, A; Rajeshkumar, NV | 1 |
| Brown, RJ; Gabrielson, E; Huso, DL; Jacobs, LK; Jeter, S; Khouri, NF; Kominsky, SL; Lange, JR; Mori, T; Powers, P; Rudek, MA; Stearns, V; Sukumar, S; Tarpinian, K; Tsangaris, TN; Yoshida, T; Zhang, Z | 1 |
1 trial(s) available for methylnitrosourea and paclitaxel
| Article | Year |
|---|---|
Preclinical and clinical evaluation of intraductally administered agents in early breast cancer.
Topics: Adult; Animals; Antineoplastic Agents; Breast Neoplasms; Carboplatin; Doxorubicin; Drug Administration Routes; Female; Fluorouracil; Humans; Mammary Glands, Animal; Mammary Neoplasms, Animal; Methylnitrosourea; Paclitaxel; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Young Adult | 2011 |
5 other study(ies) available for methylnitrosourea and paclitaxel
| Article | Year |
|---|---|
[Taxotere and methylnitrosourea: experimental appraisal of combination chemotherapy].
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Synergism; Leukemia P388; Male; Methylnitrosourea; Mice; Paclitaxel; Survival Analysis; Taxoids; Treatment Outcome | 1999 |
A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin.
Topics: Alleles; Animals; Anticarcinogenic Agents; Dexamethasone; Doxorubicin; Genes, p53; Germ-Line Mutation; Humans; Inositol; Lung Neoplasms; Methylnitrosourea; Mice; Mice, Transgenic; Nitrosamines; Paclitaxel; Proto-Oncogene Mas; Tea | 2000 |
Effect of perductal paclitaxel exposure on the development of MNU-induced mammary carcinoma in female S-D rats.
Topics: Alkylating Agents; Animals; Antineoplastic Agents, Phytogenic; Female; Infusions, Parenteral; Mammary Glands, Animal; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Methylnitrosourea; Paclitaxel; Rats; Rats, Sprague-Dawley | 2005 |
ET(B) receptor agonist, IRL 1620, does not affect paclitaxel plasma pharmacokinetics in breast tumour bearing rats.
Topics: Alkylating Agents; Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Interactions; Endothelins; Female; Methylnitrosourea; Paclitaxel; Peptide Fragments; Rats; Rats, Sprague-Dawley | 2005 |
Endothelin B receptor agonist, IRL 1620, enhances the anti-tumor efficacy of paclitaxel in breast tumor rats.
Topics: Alkylating Agents; Animals; Antineoplastic Agents, Phytogenic; Disease Progression; Endothelin B Receptor Antagonists; Endothelins; Female; Mammary Neoplasms, Animal; Methylnitrosourea; Paclitaxel; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptor, Endothelin B; Tissue Distribution | 2005 |